drugset / Trial / NCT02037165
Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers
RandomizedCrossoverSingle-blindTreatment
Summary
* To investigate the influence of different doses of BI 1026706 on the primary endpoint (PtP-amplitude LEP in UV skin) compared to placebo. * The comparison of both doses of BI 1026706 to celecoxib in the UVB treatment. * Comparison of both doses of BI 1026706 to placebo and pregabalin in the capsaicin treatment * Exploration of the pharmacokinetics of BI 1026706 * Exploration of safety and tolerability of BI 1026706
Timeline
- Start
- 2014-01-21
- Primary completion
- 2014-04-09
- Completion
- 2014-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1026706 | Unknown | — | Oral |
| Subject | Celecoxib | Other / unclassified | — | — |
| Subject | Pregabalin | Small molecule | — | — |
Indications
No indication recorded.